Nijland, H.M., Ruslami, R., Stalenhoef, J.E., Nelwan, E.J., Alisjahbana, B., Nelwan, R.H., van der Ven, A.J., Danusantoso, H., Aarnoutse, R.E. and van Crevel, R. (2006) Exposure to Rifampicin Is Strongly Reduced in Patients with Tuberculosis and Type 2 Diabetes. Clinical Infectious Diseases, 43, 848-854.
http://dx.doi.org/10.1086/507543

has been cited by the following article: